Study to Evaluate the Efficacy and Safety of PF-07055480 in Moderately Severe to Severe Hemophilia A Adults
Condition: Hemophilia A Intervention: Biological: Recombinant AAV2/6 Human Factor VIII Gene Therapy Sponsor: Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials